Neural Substrates of Gender Incongruence

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Endocrinology & Metabolism".

Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 43079

Special Issue Editors


E-Mail Website
Guest Editor
Andrology Unit, Womens’ Endocrinology, Gender Incongruence Unit, Careggi University Hospital Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy
Interests: gender incongruence; gender dysphoria; gender identity; youth; brain

E-Mail Website
Co-Guest Editor
Andrology, Women’s Endocrinology and Gender Incongruence Unit, Florence University Hospital, Florence, Italy
Interests: gender incongruence; gender dysphoria; brain sexual dimorphism; sexual medicine

E-Mail Website
Co-Guest Editor
Andrology Unit, Womens’ Endocrinology, Gender Incongruence Unit, Careggi University Hospital Department of Experimental, Clinical and Biomedical Sciences, University of Florence, Florence, Italy
Interests: gender incongruence; gender dysphoria; brain sexual dimorphism; sexual medicine

Special Issue Information

Dear Colleagues,

As many of you already know, sexual differentiation is a complex and still unclear process, influenced by both biological determinants and environmental context. Growing evidence has led us to consider the sexual dimorphic brain as the anatomical substrate of psychosexual development, in which both genes and gonadal hormones—both during intrauterine and pubertal periods—may have a role. In addition, heritability studies demonstrated a role of several genes, even if a convincing candidate gene has not been identified. Although, in recent years, the knowledge in this field has increased considerably, further studies are needed to better clarify the interactions between biological determinants of psychosexual development. With this Special Issue, we hope to encourage submissions that discuss the current state-of-the-art, address ongoing knowledge gaps, and focus on ongoing controversies related to neural substrates of gender incongruence.

We look forward to receiving your submission.

Dr. Alessandra Daphne Fisher
Dr. Carlotta Cocchetti
Dr. Jiska Ristori
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Gender incongruence
  • Sexual differentiation
  • Neuroimaging
  • Sexual dimorphic brain
  • Gender-affirming hormonal treatment

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

11 pages, 647 KiB  
Article
Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study
by Carlotta Cocchetti, Alessia Romani, Francesca Mazzoli, Jiska Ristori, Filippo Lagi, Maria Cristina Meriggiola, Giovanna Motta, Marina Pierdominici, Alessandro Bartoloni, Linda Vignozzi, Mario Maggi and Alessandra Daphne Fisher
J. Clin. Med. 2022, 11(10), 2774; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm11102774 - 14 May 2022
Cited by 3 | Viewed by 1654
Abstract
The burden of sexually transmitted infections (STIs) in the transgender population remains an underestimated issue. The aims of the present study were to evaluate the prevalence of either self-reported and serological STIs and to describe socio-demographic and clinical characteristics of transgender individuals with [...] Read more.
The burden of sexually transmitted infections (STIs) in the transgender population remains an underestimated issue. The aims of the present study were to evaluate the prevalence of either self-reported and serological STIs and to describe socio-demographic and clinical characteristics of transgender individuals with STIs. A consecutive series of 705 transgender individuals (assigned-male at birth, AMAB n = 377; assigned-female at birth, AFAB n = 328) referring to six Italian gender clinics were included. Sociodemographic and clinical information was collected during the first visit. In a subsample of 126 individuals prevalence of STIs (human immunodeficiency virus, HIV; hepatitis C, HCV; hepatitis B, HBV; syphilis) were evaluated through serology tests. The self-reported prevalence of HIV, HBV, HCV and syphilis infection in the total sample were 3.4%, 1.6%, 2.6% and 2.0%, respectively. In the subsample who underwent serological tests, higher rates of serological prevalence were found (9.5%, 4.0%, 5.6% and 7.9% for HIV, HBV, HCV and syphilis, respectively). When comparing transgender people with or without self-reported STIs, unemployment, previous incarceration, justice problems and sex work resulted more frequent in the first group (p< 0.03 for all). Regarding health status, we observed higher rates of lifetime substance abuse and psychiatric morbidities in trans people with at least one reported STI (p < 0.05). The prevalence of STIs exceeded that reported in general population and STIs correlates underline the importance of stigma and discrimination as determinants of transgender health. Full article
(This article belongs to the Special Issue Neural Substrates of Gender Incongruence)
Show Figures

Figure 1

16 pages, 13560 KiB  
Article
Characterization of the 1H-MRS Metabolite Spectra in Transgender Men with Gender Dysphoria and Cisgender People
by Sarah Collet, Sourav Bhaduri, Meltem Kiyar, Guy T’Sjoen, Sven Mueller and Antonio Guillamon
J. Clin. Med. 2021, 10(12), 2623; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm10122623 - 14 Jun 2021
Cited by 7 | Viewed by 2835
Abstract
Much research has been conducted on sexual differences of the human brain to determine whether and to what extent a brain gender exists. Consequently, a variety of studies using different neuroimaging techniques attempted to identify the existence of a brain phenotype in people [...] Read more.
Much research has been conducted on sexual differences of the human brain to determine whether and to what extent a brain gender exists. Consequently, a variety of studies using different neuroimaging techniques attempted to identify the existence of a brain phenotype in people with gender dysphoria (GD). However, to date, brain sexual differences at the metabolite level using magnetic resonance spectroscopy (1H-MRS) have not been explored in transgender people. In this study, 28 cisgender men (CM) and 34 cisgender women (CW) and 29 transgender men with GD (TMGD) underwent 1H-MRS at 3 Tesla MRI to characterize common brain metabolites. Specifically, levels of N–acetyl aspartate (NAA), choline (Cho), creatine (Cr), glutamate and glutamine (Glx), and myo-inositol + glycine (mI + Gly) were assessed in two brain regions, the amygdala-anterior hippocampus and the lateral parietal cortex. The results indicated a sex-assigned at birth pattern for Cho/Cr in the amygdala of TMGD. In the parietal cortex, a sex-assigned at birth and an intermediate pattern were found. Though assessed post-hoc, exploration of the age of onset of GD in TMGD demonstrated within-group differences in absolute NAA and relative Cho/Cr levels, suggestive for a possible developmental trend. While brain metabolite levels in TMGD resembled those of CW, some interesting findings, such as modulation of metabolite concentrations by age of onset of GD, warrant future inquiry. Full article
(This article belongs to the Special Issue Neural Substrates of Gender Incongruence)
Show Figures

Figure 1

13 pages, 3651 KiB  
Article
Replication of Previous Findings? Comparing Gray Matter Volumes in Transgender Individuals with Gender Incongruence and Cisgender Individuals
by Benjamin Clemens, Mikhail Votinov, Andrei Alexandru Puiu, Andre Schüppen, Philippa Hüpen, Josef Neulen, Birgit Derntl and Ute Habel
J. Clin. Med. 2021, 10(7), 1454; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm10071454 - 01 Apr 2021
Cited by 7 | Viewed by 5928
Abstract
The brain structural changes related to gender incongruence (GI) are still poorly understood. Previous studies comparing gray matter volumes (GMV) between cisgender and transgender individuals with GI revealed conflicting results. Leveraging a comprehensive sample of transmen (n = 33), transwomen (n [...] Read more.
The brain structural changes related to gender incongruence (GI) are still poorly understood. Previous studies comparing gray matter volumes (GMV) between cisgender and transgender individuals with GI revealed conflicting results. Leveraging a comprehensive sample of transmen (n = 33), transwomen (n = 33), cismen (n = 24), and ciswomen (n = 25), we employ a region-of-interest (ROI) approach to examine the most frequently reported brain regions showing GMV differences between trans- and cisgender individuals. The primary aim is to replicate previous findings and identify anatomical regions which differ between transgender individuals with GI and cisgender individuals. On the basis of a comprehensive literature search, we selected a set of ROIs (thalamus, putamen, cerebellum, angular gyrus, precentral gyrus) for which differences between cis- and transgender groups have been previously observed. The putamen was the only region showing significant GMV differences between cis- and transgender, across previous studies and the present study. We observed increased GMV in the putamen for transwomen compared to both transmen and ciswomen and for all transgender participants compared to all cisgender participants. Such a pattern of neuroanatomical differences corroborates the large majority of previous studies. This potential replication of previous findings and the known involvement of the putamen in cognitive processes related to body representations and the creation of the own body image indicate the relevance of this region for GI and its potential as a structural biomarker for GI. Full article
(This article belongs to the Special Issue Neural Substrates of Gender Incongruence)
Show Figures

Figure 1

23 pages, 2079 KiB  
Article
A Multi-Modal MRI Analysis of Cortical Structure in Relation to Gender Dysphoria, Sexual Orientation, and Age in Adolescents
by Malvina N. Skorska, Sofia Chavez, Gabriel A. Devenyi, Raihaan Patel, Lindsey T. Thurston, Meng-Chuan Lai, Kenneth J. Zucker, M. Mallar Chakravarty, Nancy J. Lobaugh and Doug P. VanderLaan
J. Clin. Med. 2021, 10(2), 345; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm10020345 - 18 Jan 2021
Cited by 12 | Viewed by 6565
Abstract
Gender dysphoria (GD) is characterized by distress due to an incongruence between experienced gender and sex assigned at birth. Sex-differentiated brain regions are hypothesized to reflect the experienced gender in GD and may play a role in sexual orientation development. Magnetic resonance brain [...] Read more.
Gender dysphoria (GD) is characterized by distress due to an incongruence between experienced gender and sex assigned at birth. Sex-differentiated brain regions are hypothesized to reflect the experienced gender in GD and may play a role in sexual orientation development. Magnetic resonance brain images were acquired from 16 GD adolescents assigned female at birth (AFAB) not receiving hormone therapy, 17 cisgender girls, and 14 cisgender boys (ages 12–17 years) to examine three morphological and microstructural gray matter features in 76 brain regions: surface area (SA), cortical thickness (CT), and T1 relaxation time. Sexual orientation was represented by degree of androphilia-gynephilia and sexual attraction strength. Multivariate analyses found that cisgender boys had larger SA than cisgender girls and GD AFAB. Shorter T1, reflecting denser, macromolecule-rich tissue, correlated with older age and stronger gynephilia in cisgender boys and GD AFAB, and with stronger attractions in cisgender boys. Thus, cortical morphometry (mainly SA) was related to sex assigned at birth, but not experienced gender. Effects of experienced gender were found as similarities in correlation patterns in GD AFAB and cisgender boys in age and sexual orientation (mainly T1), indicating the need to consider developmental trajectories and sexual orientation in brain studies of GD. Full article
(This article belongs to the Special Issue Neural Substrates of Gender Incongruence)
Show Figures

Figure 1

13 pages, 984 KiB  
Article
Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
by Imke Matthys, Justine Defreyne, Els Elaut, Alessandra Daphne Fisher, Baudewijntje P. C. Kreukels, Annemieke Staphorsius, Martin Den Heijer and Guy T’Sjoen
J. Clin. Med. 2021, 10(2), 296; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm10020296 - 14 Jan 2021
Cited by 9 | Viewed by 3747
Abstract
Improving transgender people’s quality of life (QoL) is the most important goal of gender-affirming care. Prospective changes in affect can influence QoL. We aim to assess the impact of initiating gender-affirming hormonal treatment (HT) on affect. In the European Network for the Investigation [...] Read more.
Improving transgender people’s quality of life (QoL) is the most important goal of gender-affirming care. Prospective changes in affect can influence QoL. We aim to assess the impact of initiating gender-affirming hormonal treatment (HT) on affect. In the European Network for the Investigation of Gender Incongruence (ENIGI) study, we prospectively collected data of 873 participants (451 transwomen (TW) and 422 transmen (TM)). At baseline, psychological questionnaires including the Positive and Negative Affect Schedule (PANAS) were administered. The PANAS, levels of sex steroids and physical changes were registered at each follow-up visit during a 3-year follow-up period, starting at the initiation of hormonal therapy. Data were analyzed cross-sectionally and prospectively. Over the first three months, we observed a decline in positive affect (PA) in both TM and TW. Thereafter, PA reached a steady state in TW, whereas in TM there was also a second decline at 18 months. In both TM and TW there was no persisting difference comparing baseline to the 36-months results. Concerning negative affect (NA), we observed a decline during the first year in TM, which sustained during the second year and was not different anymore at 36 months compared to baseline. In TW though, we did not find any change of NA during the entire follow-up. Even if some of these results show significant differences, they should be considered with caution, since there was no control group and the absolute differences are small. No association between affect and the level of sex steroids was observed. Baseline QoL and psychological burden are related to affect independently from gender but are not necessarily good predictors of the evolution of one’s affect during the gender-affirming process. Further research is necessary to investigate these preliminary results. Full article
(This article belongs to the Special Issue Neural Substrates of Gender Incongruence)
Show Figures

Figure 1

15 pages, 263 KiB  
Article
The Body I Live in. Perceptions and Meanings of Body Dissatisfaction in Young Transgender Adults: A Qualitative Study
by Marta Mirabella, Guido Giovanardi, Alexandro Fortunato, Giulia Senofonte, Francesco Lombardo, Vittorio Lingiardi and Anna Maria Speranza
J. Clin. Med. 2020, 9(11), 3733; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm9113733 - 20 Nov 2020
Cited by 24 | Viewed by 3626
Abstract
Body dissatisfaction in individuals with Gender Incongruence (GI) represents a primary source of suffering. Several studies have highlighted how this suffering has psychological, physical, and biological implications. This work aims to explore experiences related to body dissatisfaction and investigate the issues associated with [...] Read more.
Body dissatisfaction in individuals with Gender Incongruence (GI) represents a primary source of suffering. Several studies have highlighted how this suffering has psychological, physical, and biological implications. This work aims to explore experiences related to body dissatisfaction and investigate the issues associated with living in a body perceived as incongruent for individuals with GI. Thirty-six individuals, aged between 18 and 30 years old and at stage T0 of hormone treatment, participated in the study. Body dissatisfaction and experiences related to it were investigated using the Clinical Diagnostic Interview. The Consensual Qualitative Research methodology was applied to the transcripts of the interviews. Several themes emerged: experiences with GI development, experiences with puberty and bodily changes, perception of one’s body, psychological problems and complex behavioral patterns related to body dissatisfaction. Results pointed out the complexity implied in the relationship with one’s body for individuals with GI, highlighting specific aspects of body dissatisfaction among these individuals (e.g., eating disorders, sexual difficulties, social withdrawal). This study underlines the need for a deeper understanding of some aspects of GI to better define guidelines for a correct assessment of it. In this way it will be easier to avoid negative outcomes for the psychological and general health of transgender people. Full article
(This article belongs to the Special Issue Neural Substrates of Gender Incongruence)
20 pages, 2627 KiB  
Article
Neural Correlates of Gender Face Perception in Transgender People
by Alessandra Daphne Fisher, Jiska Ristori, Giovanni Castellini, Carlotta Cocchetti, Emanuele Cassioli, Stefano Orsolini, Carolina Sensi, Alessia Romani, Francesca Mazzoli, Agnese Cipriani, Valdo Ricca, Linda Vignozzi, Maria Pia Viggiano, Mario Mascalchi, Mario Maggi and Gioele Gavazzi
J. Clin. Med. 2020, 9(6), 1731; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm9061731 - 03 Jun 2020
Cited by 11 | Viewed by 5514
Abstract
To date, MRI studies focused on brain sexual dimorphism have not explored the presence of specific neural patterns in gender dysphoria (GD) using gender discrimination tasks. Considering the central role of body image in GD, the present study aims to evaluate brain activation [...] Read more.
To date, MRI studies focused on brain sexual dimorphism have not explored the presence of specific neural patterns in gender dysphoria (GD) using gender discrimination tasks. Considering the central role of body image in GD, the present study aims to evaluate brain activation patterns with 3T-scanner functional MRI (fMRI) during gender face discrimination task in a sample of 20 hormone-naïve transgender and 20 cisgender individuals. Additionally, participants were asked to complete psychometric measures. The between-group analysis of average blood oxygenation level dependent (BOLD) activations of female vs. male face contrast showed a significant positive cluster in the bilateral precuneus in transmen when compared to the ciswomen. In addition, the transwomen group compared to the cismen showed higher activations also in the precuneus, as well as in the posterior cingulate gyrus, the angular gyrus and the lateral occipital cortices. Moreover, the activation of precuneus, angular gyrus, lateral occipital cortices and posterior cingulate gyrus was significantly associated with higher levels of body uneasiness. These results show for the first time the existence of a possible specific GD-neural pattern. However, it remains unclear if the differences in brain phenotype of transgender people may be the result of a sex-atypical neural development or of a lifelong experience of gender non-conformity. Full article
(This article belongs to the Special Issue Neural Substrates of Gender Incongruence)
Show Figures

Figure 1

Review

Jump to: Research

9 pages, 383 KiB  
Review
Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
by Carlotta Cocchetti, Jiska Ristori, Alessia Romani, Mario Maggi and Alessandra Daphne Fisher
J. Clin. Med. 2020, 9(6), 1609; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm9061609 - 26 May 2020
Cited by 52 | Viewed by 11951
Abstract
Introduction: To date no standardized hormonal treatment protocols for non-binary transgender individuals have been described in the literature and there is a lack of data regarding their efficacy and safety. Objectives: To suggest possible treatment strategies for non-binary transgender individuals with non-standardized requests [...] Read more.
Introduction: To date no standardized hormonal treatment protocols for non-binary transgender individuals have been described in the literature and there is a lack of data regarding their efficacy and safety. Objectives: To suggest possible treatment strategies for non-binary transgender individuals with non-standardized requests and to emphasize the importance of a personalized clinical approach. Methods: A narrative review of pertinent literature on gender-affirming hormonal treatment in transgender persons was performed using PubMed. Results: New hormonal treatment regimens outside those reported in current guidelines should be considered for non-binary transgender individuals, in order to improve psychological well-being and quality of life. In the present review we suggested the use of hormonal and non-hormonal compounds, which—based on their mechanism of action—could be used in these cases depending on clients’ requests. Conclusion: Requests for an individualized hormonal treatment in non-binary transgender individuals represent a future challenge for professionals managing transgender health care. For each case, clinicians should balance the benefits and risks of a personalized non-standardized treatment, actively involving the person in decisions regarding hormonal treatment. Full article
(This article belongs to the Special Issue Neural Substrates of Gender Incongruence)
Show Figures

Figure 1

Back to TopTop